MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: A new mechanism for ischaemic cardioprotection

Cardiovascular Research

Volumn 84, Issue 3, 2009, Pages 434-441

  Lu, Yanjie ^a   Zhang, Yong ^a   Shan, Hongli ^a   Pan, Zhenwei ^a   Li, Xuelian ^a   Li, Baoxin ^a   Xu, Chaoqian ^a   Zhang, Bisi ^a   Zhang, Fengmin ^a   Dong, Deli ^a   Song, Wuqi ^a   Qiao, Guofen ^a   Yang, Baofeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmia; Ion channels; MicroRNA; Myocardial infarction; Propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR; CONNEXIN 43; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MICRORNA; MICRORNA 1; PROPRANOLOL; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENHANCER REGION; GENE; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART CONDUCTION; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INCIDENCE; MALE; MEMBRANE DEPOLARIZATION; MIR 1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARRHYTHMIAS, CARDIAC; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INCIDENCE; ISOPROTERENOL; MALE; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; OLIGONUCLEOTIDES, ANTISENSE; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION;

EID: 70849115884     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp232     Document Type: Article

References (40)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Yao DZL, Zhao X, Mei C. Current progress on internal medicine in China- 2006 part I. Front Med China 2007;1:235-247.
3. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996;348:7-12.
4. Larsen JA, Kadish AH, Schwartz JB. Proper use of antiarrhythmic therapy for reduction of mortality after myocardial infarction. Drugs Aging 2000; 16:341-350.
5. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
6. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A et al. The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67:I26-I32.
7. Olsson G, Rehnqvist N, Sjogren A, Erhardt L, Lundman T. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol 1985;5:1428-1437.
8. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003;93:896-906.
9. Ruffolo RR Jr, Feuerstein GZ. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. J Cardiovasc Pharmacol 1998;32:S22-S30.
10. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 2003;107: 2459-2466.
11. Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci STKE 2007;2007:re1.
12. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Car-diovasc Res 2009;82:21-29.
13. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491.
14. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H et al. The muscle-specific micro-RNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007;120: 3045-3052.
15. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N et al. MicroRNA miR-133 represses HERG Kθ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007;282:12363-12367.
16. Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE et al. miR-1 overexpression enhances Ca(2θ) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 2009;104:514-521.
17. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007;117: 2369-2376.
18. Yang B, Lu Y, Wang Z. Control of cardiac excitability by microRNAs. Car-diovasc Res 2008;79:571-580.
19. Rajan S, Radhakrishnan J, Rajamanickam C. Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart. Basic Res Cardiol 2003;98:39-49.
20. Yang B, Lin H, Xu C, Liu Y, Wang H, Han H et al. Choline produces cyto-protective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 2005;16:163-174.
21. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988;22:447-455.
22. Zhang Y, Liu Y, Wang T, Li B, Li H, Wang Z et al. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 2006;340:1192-1199.
23. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005; 436:214-220.
24. Gao H, Xiao J, Sun Q, Lin H, Bai Y, Yang L et al. A single decoy oligodeox-ynucleotides targeting multiple oncoproteins produces strong anticancer effects. Mol Pharmacol 2006;70:1621-1629.
25. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-233.
26. Nelson TJ, Balza R Jr, Xiao Q, Misra RP. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 2005;39:479-489.
27. Jeon ES, Park WS, Lee MJ, Kim YM, Han J, Kim JH. A Rho kinase/ myocardin-related transcription factor-A-dependent mechanism underlies the sphingosylphosphorylcholine-induced differentiation of mesenchymal stem cells into contractile smooth muscle cells. Circ Res 2008;103:635-642.
28. de Bakker JM, van Rijen HV. Electrocardiographic manifestation of anatomical substrates underlying post-myocardial infarction tachycardias. J Electrocardiol 2007;40:S21-S25.
29. Diaz RJ, Zobel C, Cho HC, Batthish M, Hinek A, Backx PH et al. Selective inhibition of inward rectifier Kθ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ Res 2004;95:325-332.
30. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 2008; 80:9-19.
31. Yue P, Zhang Y, Du Z, Xiao J, Pan Z, Wang N et al. Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes. Cell Physiol Biochem 2006;17:129-136.
32. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004;25:1341-1362.
33. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003;289:2560-2572.
34. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366: 1622-1632.
35. Zhang Q, Timofeyev V, Lu L, Li N, Singapuri A, Long MK et al. Functional roles of a Ca2θ-activated Kθ channel in atrioventricular nodes. Circ Res 2008;102:465-471.
36. Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M et al. Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation 2004;110:1477-1483.
37. Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E et al. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems. Am J Physiol Heart Circ Physiol 2009;296: H669-H677.
38. Davis A, Hogarth K, Fernandes D, Solway J, Niu J, Kolenko V et al. Functional significance of protein kinase A activation by endothelin-1 and ATP: negative regulation of SRF-dependent gene expression by PKA. Cell Signal 2003;15:597-604.
39. Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009;29:2193-2204.
40. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;103:18255-18260.